# SRPT: Sarepta Therapeutics,, Inc. Common Stock

- Industry: Pharmaceutical Preparations
- Current price: $20.11
- Price updated: Sep 19, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Apr 14, 2025
- Source: https://tryglasshouse.ai/companies/SRPT.md

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Apr 14, 2025, disclosed May 6, 2025
- Market context: $54.63 at trade, $20.11 current (-63.19%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/06674719-f821-4886-92ee-ccb70eb0c924.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.